These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 16113424)
1. Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease. Calverley PM Proc Am Thorac Soc; 2004; 1(2):121-4. PubMed ID: 16113424 [TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
3. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial]. Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533 [TBL] [Abstract][Full Text] [Related]
4. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations. Pauwels RA Proc Am Thorac Soc; 2004; 1(2):73-6. PubMed ID: 16113416 [TBL] [Abstract][Full Text] [Related]
5. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Ohar JA; Donohue JF Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301 [TBL] [Abstract][Full Text] [Related]
6. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!]. Rochat T Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880 [TBL] [Abstract][Full Text] [Related]
7. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM; White CM; Coleman CI Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [TBL] [Abstract][Full Text] [Related]
8. Contemporary management of chronic obstructive pulmonary disease: scientific review. Sin DD; McAlister FA; Man SF; Anthonisen NR JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189 [TBL] [Abstract][Full Text] [Related]
9. [Inhaled corticosteroids in patients with COPD: maintain current guidelines]. Heijdra YF Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568 [TBL] [Abstract][Full Text] [Related]
10. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Tashkin DP Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901 [TBL] [Abstract][Full Text] [Related]
11. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. Tashkin DP Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910 [TBL] [Abstract][Full Text] [Related]
12. The role of corticosteroids in chronic obstructive pulmonary disease. Calverley PM Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440 [TBL] [Abstract][Full Text] [Related]
13. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM; N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765 [TBL] [Abstract][Full Text] [Related]
14. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies. Wise RA; Tashkin DP Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942 [TBL] [Abstract][Full Text] [Related]
15. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD]. Yıldırım N Tuberk Toraks; 2010; 58(2):192-201. PubMed ID: 20865575 [TBL] [Abstract][Full Text] [Related]